INTRODUCTION {#s1}
============

Owing to its protected retroperitoneal location, pancreatic injury following blunt trauma is rare, with an incidence rate of \<2% \[[@RJU129C1]\]. Blunt abdominal trauma accounts for 20% of all cases of traumatic pancreatitis \[[@RJU129C2]\]. Early and accurate identification of such injuries are imperative to avoid high morbidity and mortality associated with ductal injuries. A conservative management approach has been advocated when a ductal injury is not evident. However, proponents of early surgical intervention attributed to the delay in intervention to be related with increased rates of morbidity and mortality \[[@RJU129C1]--[@RJU129C3]\]. So, an early laparoscopic approach might play a role for the diagnosis and management of blunt pancreatic injuries. Here, we report a case of traumatic pancreatitis following blunt abdominal trauma managed successfully using laparoscopic techniques.

CASE REPORT {#s2}
===========

A 28-year-old male sustained with blunt trauma to the upper abdomen. He presented with pain over epigastrium and left lower ribs. Serum pancreatic amylase and lipase levels increased from108 to 456 U/l on admission to 404 to 764 U/l in the first 24 h, respectively. An initial abdominal CT scan with IV contrast demonstrated pancreatic injury (Grade II) with peripancreatic fat stranding. Two hepatic lacerations were noted in addition to minimal subhepatic and left subdiaphragmatic free fluid (Fig. [1](#RJU129F1){ref-type="fig"}). Initially, the patient was managed conservatively and kept on nil per mouth using nasogastric decompression, intravenous fluids, analgesics and serial clinical assessment. He continued to complain of severe generalized abdominal pain with diffuse tenderness and guarding that required exploration to exclude other intra-abdominal injuries namely hollow viscus. Preoperative endoscopic retrograde cholangiopancreatography (ERCP) and magnetic resonance cholangiopancreatography (MRCP) were not performed at this stage. Exploratory laparoscopy showed moderate amount of free fluid (serosanguinous). Cytology and culture from the fluid revealed no organism growth; however, its pancreatic amylase level was 6062 U/l. Severe pancreatic reaction with saponification was seen over the thickened and contused greater omentum and bowel loops. A thorough exploration revealed no associated intra-abdominal injuries. During exploration of the lesser sac, pancreas was found to be hemorrhagic and necrotic, and the ductal injury could not be identified. Figure [2](#RJU129F2){ref-type="fig"} shows the intraoperative extension of the pancreatic necrosis that involved the entire gland. Thorough lavage of the lesser sac and peritoneal cavity were done. Two drains were inserted into the lesser sac and pelvis following which the procedure was terminated without conversion. Figure 1:CT abdomen showing two hepatic lacerations in addition to minimal subhepatic and left subdiaphragmatic free fluid. Figure 2:The intraoperative extension of the pancreatic necrosis that involves the entire gland.

The high serum amylase and lipase levels were normalized within 2 days postoperative. On the third postoperative day, clinical examination and chest X-ray demonstrated left-sided pleural effusion (Fig. [3](#RJU129F3){ref-type="fig"}). On the fifth day, nasojejunal tube feeding was introduced. Follow-up MRCP revealed complete transection of the pancreatic duct at the junction of pancreatic neck and body (Grade III). Output from the abdominal drains showed a gradual decline in the amount of drained fluid. On the 28th day, drains were dropped off successfully. Follow-up CT showed a small peripancreatic collection of ∼4 cm. The patient was discharged on the 36th postoperative day. Figure 3:Chest X-ray demonstrated a large left-sided pleural effusion.

A 6-month out-patient abdominal CT follow-up showed no fluid collection and the patient was asymptomatic.

DISCUSSION {#s3}
==========

Definite management of pancreatic injuries is not well defined yet. Moreover, the clinical and laboratory findings of blunt pancreatic injury are nonspecific, and therefore accurate diagnosis in its acute phase is usually delayed \[[@RJU129C1], [@RJU129C3]\]. Computed tomography scanning may fail to delineate the pathology, especially in the initial stage. Also, the ability for CT to demonstrate the integrity of pancreatic duct is limited (43%); however, multiple detector computed tomography may have better result \[[@RJU129C1], [@RJU129C4], [@RJU129C5]\].

MRCP allows direct imaging of the pancreatic duct and its disruption \[[@RJU129C1]\]. ERCP seems the most reliable diagnostic tool to accurately define the continuity of the main pancreatic duct following pancreatic trauma with a 100% sensitivity and specificity \[[@RJU129C6]\]. However, the need for a skilled endoscopist and the invasive nature of procedure may limit its use in unstable patients. Suspicion of concomitant traumatic intra-abdominal injuries prompts the surgeon to choose exploration over ERCP. Pancreatic lacerations not involving the duct (The American Association of Surgeons in Trauma Grade I and II) are considered minor injuries and are predominantly managed conservatively. Grade III--V injuries usually necessitate surgical exploration depending on the degree of injury and its proximity to the mesenteric vessels; where distal pancreatectomy is the most common approach \[[@RJU129C7]\]. Kantharia *et al.* \[[@RJU129C8]\] studied 17 cases with pancreatic trauma and found that contrast-enhanced CT as the useful tool for diagnosis and grading of the pancreatic injuries. Moreover, the majority of these cases responded well to the conservative treatment; however, higher grade pancreatic injury required surgical intervention but with higher mortality.

In patients with blunt pancreatic trauma, delayed morbidities include pancreatitis, fistula, abscess, pseudocysts and major duct strictures \[[@RJU129C9]\]. Therefore, we assume a valid role for early laparoscopic approach for suspected injuries. This is particularly compelling when CT scan is inconclusive and patients show signs suggestive of peritonism. Intraoperative diagnosis of ductal injuries is seldom done owing to its complexity and retrograde pancreatography through a small duct is often difficult in trauma patients.

Our patient\'s clinical deterioration precluded the use of preoperative ERCP/MRCP. Clinical suspicion for hollow viscus injury prompted diagnostic laparoscopy. Necrotic and hemorrhagic pancreas precluded any intraoperative attempt to accurately characterize extent of ductal injury. Looking retrospectively, we acknowledge that, if we were able to diagnose ductal transection pre/intraoperatively, our management would have drastically deferred towards distal pancreatectomy.

In addition to being an exploratory, laparoscopy can be effectively used to characterize pancreatic injuries (grading) that informs the management with immediate drainage for the proximal pancreatic part or the resection of the distal injuries, whenever indicated \[[@RJU129C10]\]. Therefore, a laparoscopic approach provides a genuine alternative to the open abdominal surgery.

In conclusion, the management of blunt pancreatic injuries should be tailored to individual situations. In selected patients with worsening symptoms, a prompt trial of laparoscopy is an useful option. Although we chose a conservative drainage approach due to inconclusiveness on the integrity of pancreatic duct, we were able to achieve a favorable result. Further studies are needed to confirm our findings.
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